Project Details
| Status | Active |
|---|---|
| Effective start/end date | 08/23/24 → 08/18/26 |
Funding
- United Therapeutics Corporation: $45,520.10
Randomized Double Blind Placebo Controlled Multinational Phase 3 Study of Efficacy & Safety of Inhaled Treprostinil in Subjects with Progressive Pulmonary Fibrosis (TETON-PPF)
- Desai, Alpa (PI)
- Alexander, Krystal (CoPI)
Project: Research